Product Information
TETRABENAZINE 12.5 MG TABLET is a generic product labeled by Bionpharma Inc., priced at $0.8066 per EA under NDC 69452011721. Its NADAC has been published 175 times since Feb 22, 2023.
Strength
12.5 mg/1
Manufacturer
Bionpharma Inc.NDC
69452011721
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
TETRABENAZINEApproval Type
Generic (ANDA)
FDA Application
ANDA208826On Market Since
1/15/2018
Pharmacological Classes
Price Statistics
The NADAC for TETRABENAZINE 12.5 MG TABLET has been published 175 times since Feb 22, 2023, and over the history we have for it it has declined 68.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.8066 per EA |
|---|---|
| All-time high | $3.2465 (Dec 13, 2023) |
| All-time low | $0.7645 (Sep 17, 2025) |
| 52-week high | $1.1399 |
| 52-week low | $0.7645 |
| Median price | $1.4658 |
| Average price | $1.7204 |
| Largest weekly change | -63.3% (Dec 20, 2023) |
| Weeks tracked | 175 |
| Tracking since | Feb 22, 2023 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of TETRABENAZINE 12.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for TETRABENAZINE 12.5 MG TABLET, manufactured by Bionpharma Inc., is $0.8066 per EA (NDC 69452011721), effective Jun 24, 2026.
How has the price of TETRABENAZINE 12.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for TETRABENAZINE 12.5 MG TABLET has declined 68.9%. It has been tracked across 175 weekly CMS publications since Feb 22, 2023.
What are the highest and lowest recorded NADAC prices for TETRABENAZINE 12.5 MG TABLET?
Since Feb 22, 2023, the NADAC for TETRABENAZINE 12.5 MG TABLET has ranged from a low of $0.7645 (Sep 17, 2025) to a high of $3.2465 (Dec 13, 2023), with a median of $1.4658 per EA.
Are there cheaper alternatives to TETRABENAZINE 12.5 MG TABLET?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as TETRABENAZINE 12.5 MG TABLET, but none are currently priced below it.
Who manufactures TETRABENAZINE 12.5 MG TABLET?
TETRABENAZINE 12.5 MG TABLET (NDC 69452011721) is labeled by Bionpharma Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification